Startups
2018
AORTYX SLThe ultimate solution for aortic diseases
Adhesive endovascular patch that promotes tissue regeneration and false lumen thrombosis.
Adhesive endovascular patch that promotes tissue regeneration and false lumen thrombosis.
Finance Data
CERCA ownership
Other Catalan Public owners
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Aortyx is a pioneer company that aims at providing a new generation of endovascular devices to treat vascular diseases.
Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
At Aortyx, we aim at delivering the ultimate solution for aortic diseases, tackling clear unmet needs, generating positive impact in our society with the most advanced available technology.
Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
At Aortyx, we aim at delivering the ultimate solution for aortic diseases, tackling clear unmet needs, generating positive impact in our society with the most advanced available technology.
Product description
Bioresorbable - Our material has been designed to dissolve progressively two years after its implantation. No toxic nor inflammatory responses are expected.
Viscoelastic - The microstructure of our device is specially designed to mimic the mechanical properties of the aorta. Our patch has the ability to expand and contract with every cardiac cycle.
Thrombogenic - Controlled clotting of the false lumen allows a better restoration of flow through the true lumen and to avoid peripheral malperfusion.
Regenerative - The extracellular matrix molecules that decorate the patch promote re-endothelialization of the affected dissected part.
Drug delivery platform - Our device could be used as a local drug delivery platform thanks to the specially designed microstructure and the material used to create it.
Viscoelastic - The microstructure of our device is specially designed to mimic the mechanical properties of the aorta. Our patch has the ability to expand and contract with every cardiac cycle.
Thrombogenic - Controlled clotting of the false lumen allows a better restoration of flow through the true lumen and to avoid peripheral malperfusion.
Regenerative - The extracellular matrix molecules that decorate the patch promote re-endothelialization of the affected dissected part.
Drug delivery platform - Our device could be used as a local drug delivery platform thanks to the specially designed microstructure and the material used to create it.